|
Valoración de DCF de Singular Genomics Systems, Inc. (OMIC)
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Singular Genomics Systems, Inc. (OMIC) Bundle
Diseñada para la precisión, nuestra calculadora DCF (OMIC) le permite evaluar la valoración de Singular Genomics Systems, Inc. utilizando datos financieros actualizados al tiempo que proporciona flexibilidad integral para modificar todos los parámetros clave para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .8 | 2.9 | 3.6 | 4.5 | 5.7 | 7.1 | 8.9 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 280.52 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | -12.0 | -26.4 | -60.5 | -84.1 | -86.5 | .7 | .9 | 1.1 | 1.4 | 1.8 |
| EBITDA, % | 100 | 100 | 100 | -10991.37 | -2971.35 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | .4 | .6 | 1.1 | 6.0 | 7.2 | 3.6 | 4.5 | 5.7 | 7.1 | 8.9 |
| Depreciation, % | 100 | 100 | 100 | 788.5 | 248.13 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -12.3 | -27.0 | -61.7 | -90.1 | -93.7 | .7 | .9 | 1.1 | 1.4 | 1.8 |
| EBIT, % | 100 | 100 | 100 | -11779.87 | -3219.48 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 46.2 | 26.9 | 339.2 | 244.6 | 173.9 | 3.6 | 4.5 | 5.7 | 7.1 | 8.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 1.1 | 2.0 | 1.6 | 3.3 | 4.1 | 5.2 | 6.5 | 8.1 |
| Account Receivables, % | 100 | 100 | 100 | 263.01 | 54.41 | 90.88 | 90.88 | 90.88 | 90.88 | 90.88 |
| Inventories | .0 | .0 | 3.0 | 18.2 | 13.6 | 3.6 | 4.5 | 5.7 | 7.1 | 8.9 |
| Inventories, % | 100 | 100 | 100 | 2381.83 | 466.23 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .6 | .4 | 2.3 | 3.1 | 2.6 | 3.6 | 4.4 | 5.6 | 6.9 | 8.7 |
| Accounts Payable, % | 100 | 100 | 100 | 405.1 | 88.87 | 97.77 | 97.77 | 97.77 | 97.77 | 97.77 |
| Capital Expenditure | -.8 | -1.4 | -4.9 | -6.0 | -1.0 | -1.0 | -1.2 | -1.5 | -1.9 | -2.4 |
| Capital Expenditure, % | 100 | 100 | 100 | -787.19 | -33.32 | -26.66 | -26.66 | -26.66 | -26.66 | -26.66 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -12.3 | -27.7 | -61.8 | -87.5 | -93.7 | .7 | .9 | 1.1 | 1.4 | 1.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -12.2 | -28.6 | -67.6 | -102.9 | -82.9 | 12.6 | 3.4 | 4.2 | 5.3 | 6.6 |
| WACC, % | 7.22 | 7.22 | 7.22 | 7.14 | 7.22 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 26.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 7 | |||||||||
| Terminal Value | 130 | |||||||||
| Present Terminal Value | 92 | |||||||||
| Enterprise Value | 119 | |||||||||
| Net Debt | 59 | |||||||||
| Equity Value | 60 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | 24.55 |
What You Will Get
- Real OMIC Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Singular Genomics Systems, Inc.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to [OMIC].
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Singular Genomics' fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for [OMIC].
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Singular Genomics Systems, Inc.
Key Features
- Comprehensive Genomic Analysis Tools: Offers advanced tools for sequencing and data analysis tailored for genomic research.
- Customizable Bioinformatics Solutions: Pre-configured bioinformatics pipelines with options for user-defined parameters.
- Flexible Data Integration: Easily integrate various data types, including genomic, transcriptomic, and proteomic data.
- Built-In Analytical Metrics: Evaluate key performance indicators for genomic data interpretation.
- User-Friendly Dashboard: Interactive visualizations provide a clear overview of genomic insights and trends.
How It Works
- 1. Access the Template: Download and open the Excel file containing Singular Genomics Systems, Inc.'s preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making process.
Why Choose This Calculator for Singular Genomics Systems, Inc. (OMIC)?
- Accurate Data: Utilize real financials from Singular Genomics for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Ready-made calculations save you the effort of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: An intuitive design and clear step-by-step guidance make it accessible for all users.
Who Should Use This Product?
- Investors: Evaluate Singular Genomics' (OMIC) market position before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for accuracy.
- Biotech Entrepreneurs: Understand the valuation strategies of leading genomic companies like Singular Genomics.
- Consultants: Provide comprehensive valuation analyses and reports for biotechnology clients.
- Students and Educators: Utilize current genomic industry data to learn and teach valuation practices.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Singular Genomics Systems, Inc. (OMIC).
- Real-World Data: Singular Genomics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Interactive charts and tables for clear, actionable results.